Avenir Wellness Solutions Inc (AVRW)

[myearnings]

Cure's agreements so far appear to not demonstrate real revenue growth expected for products launched. The Cure Sleep product revenues since their agreement is minimal vs the projections and now Q1 2019 related revenues reveal further decline. With continued costs rising existing launched products need to demonstrate revenues projected and growth. Cure's pipeline of products and patents are significant and so should the efforts demonstrating meeting projections.